top of page
Media
Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development
Business Wire
August 10, 2022
Press Release: Prellis Biologics Announces Collaboration with Sanofi
Business Wire
March 22, 2022
Press Release: Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb
Business Wire
January 13, 2022
bottom of page